New Delhi: Prof. Dr. Divya Vohora Professor, Department of Pharmacology, Jamia Hamdard has been elected as the Fellow of the Royal Society of Biology, London on 1st April, 2021. The Fellow of the Royal Society of Biology (FRSB) is an award and fellowship granted to individuals that the Royal Society has adjudged to have made a prominent contribution to the advancement of the biological sciences. It acknowledges significant achievements by a professional for the extraordinary contributions to the field of Life sciences. The elected Fellows are given the designation of Fellow of the Royal Society of Biology (FRSB).
Prof. Divya Vohora has received this fellowship for her extensive contributions in the field of Pharmacology particularly Neuropharmacology, Epilepsy and Osteoporosis. She has provided innovative insights in understanding the novel mechanisms and new drug targets for epileptogenesis and epilepsy particularly temporal lobe epilepsy, the most drug-resistant form of epilepsy. In addition, she has carried out research on mitigating the adverse effects of various drug treatments on bone.
Her major areas of interests are Neurobehavioral Pharmacology particularly Epilepsy and epilepsy-associated complications, neuropsychiatric and neurodegenerative diseases including Alzheimer’s disease and associated co-morbidities including osteoporosis.
About Prof. Dr. Divya Vohora
Prof. Dr. Divya Vohora is a recipient of Distinguished Woman Scientist Award of Indian Society of Chemists and Biologists (ISCB), Dr. Vinod Kumar Bhargava Award of National Academy of Medical Sciences (NAMS); Dr. D. N. Prasad Memorial Oration Award of Indian Council of Medical Research (ICMR); Career Award for Young Teachers by AICTE; Fast Track Award for Young Scientists by DST and Chandra Kanta Dandiya Prize for best published paper in Pharmacology.
She has published over 200 papers in national and international journals of repute and is also the author/editor for 4 books published by Elsevier, Springer Nature and CRC Press, Florida.
She is member of the International Advisory Group of British Pharmacological Society, UK and is an expert member for research grants submitted to National Science Centre, Poland and La Caixa Foundation, Spain.
Dr. Vohra laboratory has identified novel targets for epilepsy and epileptogenesis and addressed several epilepsy-associated complications. Her work identified various therapeutic options for possible exploration as an adjunct to conventional antiseizure drugs in preventing neurodegenerative processes of temporal lobe epilepsy. New mouse models were developed for secondary osteoporosis in mice and novel biomarkers for epilepsy were investigated with a focus on aromatase, histamine H3 receptor antagonism and PI3K-mTOR pathway as some potential targets.